Hematology Conferences | Hematology Meetings |Hematology Congress 2024

Hematology Conferences, Blood Cancer Conferences Europe, Hematologic Oncology Conferences USA, Leukemia Conferences 2024 Asia, Japan Conferences on Blood Disorders, Middle East Hematology Meetings, Lymphoma Conference in UK,

Renowned Speakers

Anitha Gopal

Fortis hospitals India

Madhuri M. Sopirala

University of Cincinnati Health USA

Vitor H. Pomin

Federal University of Rio de Janeiro Brazil

Heiko Konig

Johns Hopkins University USA

Rachana

Jaypee Institute of Information Technology India

Helen Philippou

University of Leeds UK

Yathish Kumar

Karnataka cancer hopsital & research centre India

Christian Drapeau

Stemtech International Inc. USA

Recommended Global Hematology Webinars & Conferences

Europe & UK

Cancer Research 2024, Switzerland Eurometabolomics-2024, Spain WORLD CARDIOLOGY 2024, UAE

Asia Pacific & Middle East

Nursing Education-2023, Japan Cancer Care 2023, Malaysia Parasitology-2023, Singapore

Canada

Cardiac Surgery 2023, Canada Heart Care-2023, Canada Mech Aero 2023, Canada

Hematology Congress 2024

About Conference

Hematology Congress 2023 board are pleased to welcome you to join the forthcoming "22^nd World Hematology Congress" on February 19-20, 2024 London, UK. This congress is estimated to be the most significant and best dais for every one of the Scientists, Hematologists, Oncologists, Pathologists, Surgeons, Nurses, Research Scholars, Business Professionals, and Students who are working in the part of Hematology.

Theme: Beyond Blood: Expanding Horizons in Hematology

Hematology Congress 2024 contains speaker oral discussions, banner introductions, brief feature introductions, studios and shows. Here scientists and affiliations will trade thoughts and talk about the Management and Care of Patients, new methodologies arising in Hematology and furthermore progressed procedure for Diagnostics and treatment for Hematologic Disorders and so forth.

CME Accredited Haematologists’ 2024 will be coordinated by Conference Series Ltd which is contained 3000+ Global Events with over 1000+ Conferences, 1200+ Symposiums and 1200+Workshops on assorted Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management field is putting together gatherings wherever the world. Gathering Series Ltd through its global meetings gives a sublime chance to the sprouting researchers and youthful analysts through its uncommon drives like Young Researcher Forum, Poster Presentation and E-banner and Live Streaming, B2B and Scientific Meetings.

Why to join the event?
Hematology Congress 2024 will give a logical climate and a stage for the members to trade their perspectives and thoughts in regards to Hematology research. Specialists and Associations from around the globe zeroed in on finding out with regards to Leukemia, Hemophilia, Blood coagulating and Hematologic Oncology can include in joint effort and systems administration; An incredible opportunity to arrive at a colossal array of members from the Hematology people group to battle against these dangerous problems.

Target Audience

Hematologists
Oncologists
Haematopathologists
Scientists
Young Researchers
Medical Students
Physicians/Consultants/ General Practitioners
Nurses
Residents
Directors/Managers
Pathologists
Presidents & Vice Presidents/ Directors / Administrators
Business Entrepreneurs
Haematology Pharma Companies
Medical Devices Companies
Hematology Associations/ Societies.

Renowned Award for Young Research's at Hematology Congress 2024 - Discovering New Exploration in Hematology field
Hematology Conference Committee is happy to declare "22^ndWorld Hematology Congress" February 19-20, 2024 by focusing on the topic: "An Insight into Hematology, Oncology and Blood Disorders ". Hematology Congress 2024 improvements are keeping up with their energy. Hematology Conference program digs into vital conversations.

Hematology Congress 2024 Young Scientist Awards:
Hematology Conference Committee is expected to respect esteemed honor for skilled Young analysts, researchers, Young Investigators, Post-Graduate understudies, Post-doctoral colleagues, Trainees, Junior staff in acknowledgment of their remarkable commitment towards the gathering subject. The Young Scientist Awards bend over backward in giving a solid expert improvement opportunity for early profession academicians by meeting specialists to trade and share their encounters on all parts of Hematology.

Youthful Research's Awards at Hematology Congress 2024 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate theory work Presentation, just 25 introductions OK at the Hematology Congress 2024 youthful exploration discussion.

Rules for Young Researchers Forum
Benefits:
Youthful Scientist Award acknowledgment declaration and keepsake to the victors.
Our meetings give best Platform to your examination through oral introductions.
Find out with regards to profession improvement with every one of the most recent advances by systems administration.
Youthful Scientists will get proper and opportune data by this Forum.
Stage for coordinated effort among youthful analysts for better turn of events.
Give a chance to explore collaboration and set up senior agents across the globe in the field.
Offer the thoughts with both prominent analysts and guides.
It's an incredible advantage for youthful specialists to find out with regards to the examination regions for extending their exploration information.

Qualification:
Youthful Investigators, Post-Graduate understudies, Post-doctoral colleagues, Trainees, Junior staff with at least 5 years of exploration experience
Show should be into logical meetings of the gathering.
Every Young Researcher/Young Scientist can submit just one paper (as first creator or co-creator).
Age limit-Under 35yrs
All entries should be in English.

Sessions & Tracks

Track 1: Hematology and Cardio-Oncology
Cardiovascular issues through blood and consequently the framework that gives research facility esteems with respect to blood, the circulatory framework and gets cardiovascular infections from the Chinese medication and western medication points of view. Cardio-Oncology is to search out a harmony between oncologic adequacy and diminishing adversarial cardiovascular impacts over opportune distribution and broadcasting of exploration. Cardiovascular imaging and transthoracic echocardiography assume a significant part inside the benchmark evaluation and sequential development of cardio-oncology patients. Logical sign in the organization of cardiovascular hitches of onco-hematological patients is uncommon, as these patients have been methodicallly excluded from clinical preliminaries and cutting-edge endorsements depend on master assent. Cardio-onco-hematology which license its case in normal clinical readiness so to advertise the development of nearby multidisciplinary teams, to energize the cardiovascular wellbeing of patients with malignancy.

European Hematology Societies:
European Society of Hematology, British Society of Hematology, International Society of Hematology, European Society of Paediatric Hematology Oncology, Sociedad Espanola de Hematology Hemotherapy

Asian Oncology Societies:
Asian Oncology Nursing Society (AONS), Asian Society of Gynecologic Oncology (ASGO), Asian Society of Head & Neck Oncology (ASHNO), Federation of Asian Organization for Radiation Oncology (ARO)

USA Hematology Societies:
American Society of Hematology, International Society for Laboratory Hematology, The Canadian Hematology Society, Michigan Society of Hematology, American Society of Clinical Oncology

USA Oncology Societies:

American Cancer Society (ACS), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), American Society of Clinical Oncology (ASCO)

Asian Hematology Societies:
Emirates Society of Hematology, Saudi Society for Hematology, Hematology Society of Australia and new Zealand, Malaysian Society on Hematology, American Hematology Association.

European Oncology Societies:
European Society for Gene and Cell Therapy, International Society for Stem Cell Research (ISSCR), UK Oncology Nursing Children’s Cancer and Leukemia Group Society, European Society of Oncologic Imaging, European Association for Cancer Research.

Track 2: Vascular Bleeding Disorders
Haemorrhage disorders are induced by vascular abnormality or debilitation. They are connected with cutaneous or mucosal level or discernible purpura. These problems are a heterogeneous gathering of conditions classified by simple staining, petechiae, mucosal dying, ecchymosis, and imprudent draining from little vessels. The central defect is expressed to be also in the actual vessels or in the perivascular connective tissue. Worth focusing on, the generally utilized "purpura" is normally depicted subcutaneous dying, which will be connected to vessel divider irregularities (portrayed here) or platelet anomalies. Of which some are inherited and keeping in mind that the others are procured.

USA Oncology Societies:
American Cancer Society (ACS), American Association for Cancer Research (AACR), International Agency for Research on Cancer (IARC), American Society of Clinical Oncology (ASCO)

Track 3: Neuro-hematology
The crossing point amongst hematology and neurology is comprehensive, and neurological complications within the course of hematologic ailment are recurrent and diverse. Polycythemia, in which there are, increased numbers of red blood cells with iron deficient. Polycythemia and therefore the comparative Sideropenia cause amplified blood viscosity with connected neurological symptoms and signs. Haematological conditions that lead into neurological manifestations are Thrombophilia, antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, sickle cell, myeloma, leukemias, lymphomas and clonal disorders. These are considered into benign and malignant situations.

Track 4: Transfusion Medicines
Blood Transfusion is a clinical practice where given blood is bonded to a beneficiary. It is a lifesaving, harmless system. These are wont to deal with a few ailments like iron inadequacy Anemia, red platelet disease, extreme drain for the most part from a medical procedure, labor, or a huge destiny. What is all the more entire blood or blood parts (red platelets, white platelets, plasma and thickening elements) are castoff relying upon the condition of the patient. For the reasoning that top of the line clinical associations, the interest for blood and blood parts is expanding consistently wherever the planet. The order for blood is continuously developing though a few parts of medications have cut down its certainty. There will be change of bonding offices for better viability and fix conveyance. The quantity of blood donation centers will drop, and high-volume, actually up-climbed focal blood donation centers will work in their place to reduce the costs of method. All together, we foresee great situations for bonding medication experts constantly 2025, at the best inside the agricultural nations. Bonding medication has great forthcoming R&D approaches in substantial cell Research.

Track 5: Hematology Nursing
Hematology clinical chaperons are the experts in dealing with the patients with blood related diseases. They understand patients' clinical record, and that they will assist the hematologist with examining and treat the blood related ailments. The most basic thing is to encourage the patients to manage the diseases heroically. They can suggest the solution as they think about the condition of the condition. They possibly spread their help with the transplantation of the blood too. Remembering the ultimate objective to pursue the learning of hematology nursing, one should complete the acknowledgment in nursing or long term school instruction in nursing and the monstrous sensation of sureness happens when they have the inclusion in the specific field. Hematology nursing is regularly related to the hematology oncology.

Track 6: Case Reports in Hematology
A case report is generally viewed as a sort of episodic verification. Given their natural technique restrictions, including nonattendance of factual testing, case reports are set at the foot of the order of clinical verification, close to case series. Be that as it may, Hematology case reports do play really accommodating parts in clinical examination and proof based medications. In particular, they have worked with acknowledgment of late sicknesses and unfriendly impacts of therapies. For example, acknowledgment of the connection between organization of teratogen to moms and abnormalities in their infants was recommended by the report of a chose case. Case reports have an assignment in pharmacovigilance. They will furthermore work with comprehend the clinical range of uncommon infections, also as remarkable introductions of normal sicknesses. They can work with produce study theories, just as conceivable systems of infection. Case reports may moreover have an errand to play in directing the personalization of medicines in clinical follow. Accordingly incorporate case reports in Hematologists meetings.

Track 7: Hematologic Cancers
Hematologic malignancy is the generally spread and most normal problem among other Blood issues and is a vital part of Blood issue research. Blood malignancies influence the presentation and arrangement of your platelets. Carcinogenic cells confine your blood from playing out its significant/normal capacities, such as restricting from genuine draining or battling with unfamiliar body/diseases specialists. A boss a piece of blood-put together examination goes with respect to during this field. Leukemia for the most part influences the white platelets (WBCs) and is firmly connected to the lymphomas and some of them are profoundly identified with the grown-up T cells leukemia, these issues goes under the lymph proliferative problems. The malignancy which begins from WBCs (white platelets) is known as lymphoma and this kind of turmoil is chiefly found in Hodgkin lymphoma these sicknesses can be treated with hematopoietic foundational microorganism transplantation, radiation treatment and chemotherapy. The bone marrow in which many white platelets foster that prompts numerous myeloma.

Track 8: Blood Disorders: Diagnosis and Treatment
For the rule identification of blood issues, a Physician for the most part go for Complete blood check (CBC). This is the fundamental test then, at that point to analyze a singular's blood sickness, the specialist normally should do additionally blood tests. Once a specialist/advisor finds that something isn't right with the blood corpuscle types, numerous extra tests are accessible for additional identification of illness. Specialists can gauge extent of the various kinds of WBCs (white platelets) and can likewise decide subtypes of these cells by surveying certain markers on the outer layer of the cells. Appraisals are made to gauge the limit of white platelets to battle unfamiliar body/contamination, to assess the working of blood platelets and their capacity to clump and to really look at the substance of red platelets to assist with deciding the reason for frailty or why the cells are not working as expected. A large portion of these tests are done on blood tests, however at some point require a bone marrow test also for Bone Marrow Examination. In view of the analysis, Hematologists pick the adept treatment for explicit issue. Present days we've various ways to deal with treat blood malignancies like Chemotherapy, radiotherapy and so forth The present progressed strategies, for example, quality treatment is being utilized to treat Blood sicknesses. Specialists are trying to look out ways that to address the imperfect qualities that cause Blood Disorders. By the by, Gene treatment hasn't set up to the purpose that it's acknowledged treatment for blood sickness. However, specialists actually investigate quality treatment in clinical preliminaries. Bone Marrow Transplantation, Hematopoietic immature microorganism treatment and Cord blood transplantation are new rising assortments of treatment for blood problems.

Track 9: Cancer Genomics & Metabolomics
Malignancy Genomics and Metabolomics. Malignancy genomics is a sub-field of genomics that exemplifies disease connected or malignancy related qualities. Though Metabolomics is the evaluation of little particles framed by metabolic movements inside an organic model. Metabolomics datasets contain an abundance of information that mirror the infection state and are resulting to both hereditary variety and climate. Since malignant growth is a genomic sickness, genomic profiling is an irrefutably significant instrument for accuracy oncology. Accuracy Oncology insinuates the fitting of remedial malignancy treatment to the singular characteristics of each quiet.

Track 10: Digital Imaging in Hematology
Improvements in electronic imaging, PCs, and the Internet have led to in the fast rise of advanced imaging in pathology. The Bloodhound framework is an instrument that is intended to print blood onto a slide with a controlled technique, naturally stain cells, play out a CBC with WBC differential, and find WBCs by advanced imaging, all in an analyser with an impression of 42 inches. Unimportant Hematology Analyzer Plus Blood Smear Digital Imaging/Analysis make accessible preferable Clinical Hematology results over a Compound Hematology Analyzer. Advanced Imaging works in day by day schedule for leukocytes in fringe blood and different liquids, is solid, exact and shows a high impact cell sensitity.

Track 11: Organ Specific Cancer
The second preeminent premise of death on the planet close to cardiovascular infections is Cancer. Various kinds of diseases influence different organs of the body, generally of them are Brain malignancy, Head and Neck Cancer, Oral disease, Lung malignant growth, Breast malignancy, Liver malignant growth, Prostate disease, Gastric malignancy, Pancreatic malignancy, Kidney (Renal Cell) malignant growth, Leukemia and various. Most normal spots that are affected by malignancy in men are Lung, prostate, colon, rectum, stomach and liver, while in ladies are bosom, colon, rectum, lung, cervix and stomach. Pointing malignant growth digestion has the probability to direct to significant advances in disease recuperating. Ongoing advancements in determination and treatment of malignant growths have coordinated to an ascent in disease endurance and subsequently, there is a more noteworthy accentuation on quality close to amount of endurance. Included investigation the quality-situated malignant growth cures primes to quality-arranged lives in approaching. According to the estimations of scientists till now in excess of 200 sorts of the tumors have been recognized. The hazard do expose to, upon the space/Organ required by Cancer.

Track 12: Hematopoietic Malignancies
Hematopoietic malignant growths are tended to cancers of framework cells. A large portion of them are incorporated of cells that are practically heterogeneous with just a development being answerable for cancer care. Leukemias are "fluid growths" inside the blood and are gotten from the change of either a hematopoietic forerunner inside the bone marrow or a developed hematopoietic cell inside the blood. Leukemias are regularly lymphoid or myeloid, and intense or persistent. Most hematopoietic malignancies are included cells that are practically heterogeneous with just a subset being responsible for growth upkeep. The exhaustive keen of amassing of hereditary/epigenetic occasion movements could prime to advancement of therapeutics that all the more successfully treat hematopoietic malignancies and possibly different diseases. Hematopoietic tumors (HCs) are malignancies of framework cells, identified with gross chromosomal anomalies like movements. Upgrades in conclusion and treatment, including hematopoietic physical cell transplantation and atomically designated techniques, have expanded patient endurance.

Track 13: Stem Cell Therapy
Foundational microorganism treatment is the treatment where undifferentiated organisms are utilized to forestall a sickness or condition. Haematopoietic undifferentiated cells are normally gotten from bone marrow, or fringe blood. Bone marrow transplantation is generally utilized immature microorganism treatment. It could be autologous, allogeneic or syngeneic. Foundational microorganism research manages exploration and distribution of excellent compositions identified with undifferentiated organisms. Immature microorganisms are cells of multicellular life forms that can separate into different kinds of cells. They can separate more cells of similar sort of foundational microorganisms. For a cell to be viewed as an undifferentiated organism, it ought to act naturally recharging and should be either totipotent or pluripotent. Different sorts of foundational microorganisms like undeveloped undifferentiated organisms, fetal and grown-up undeveloped cells tissue explicit immature microorganisms, haemopoietic undifferentiated organisms, disease undifferentiated organisms are known. Haemopoietic foundational microorganisms that lead to other platelets by an interaction called Hemopoiesis in the red bone marrow. Haemopoietic undeveloped cell transfers are utilized in the therapy of malignancies and other safe framework issues.

Track 14: Cord Blood Transplantation
One of three establishments of blood-framing cells utilized in transfers are Cord Blood though the other two bases are bone marrow and fringe blood immature microorganisms. The vaccination of umbilical rope blood to restore a person's own blood creation framework impeded by anticancer medications, radiation treatment, or both. Human cryopreserved CD34+ cells from line blood, bone marrow, and Mobilized blood. CD34+ cells separate into any remaining white platelets. More Cells Significant Results Types: Cells, Media, Assays. Malignant growths are frequently treated through physical cell transfers, including fringe blood, bone marrow, and rope blood transfers. The main fruitful string blood relocate (CBT) was cleared out 1988 during a youngster with Fanconi Anemia. The hypothesis of the learning is twofold unit umbilical line blood transplantation in grown-ups will identify with a one-year perseverance pace of basically 40%.

Track 15: Clinical Haematology
It is the part of clinical treatment that arrangements with distinguishing proof and treatment of blood diseases and blood malignances. This incorporates management of chemotherapy and bonding. Clinical Hematology specialists are managed in the accompanying regions haemato-oncology, hematology and bone marrow transplantation, head the clinical offices (Adult and Pediatric) alongside a Haemato-Pathologist, assistant in hematopathology conveniences. Diseases relieved under clinical Hematology: Acute Leukemia, Chronic Leukemia, Plasma Cell issues, Lymphoma – Hodgkin/Non-Hodgkin, Myeloproliferative Neoplasms, Thalassemia and different haemoglobinopathies, All sorts of coagulation and thrombotic problems and Hemoglobin and platelet issues.

Track 16: Pediatric Hematology
Pediatric hematology is a part of hematology managing the overall hematological issues found in children or pediatric patients. Different issues like blood tallies, Polycythaemia, Neonatal iron deficiency, Anemia of rashness, hemolytic paleness inside the youngster, Congenital red cell surrenders, procured red cell deserts, Hyperbilirubinemia, Congenital dyserythropoietic sickliness, Acquired red cell aplasia, Neutropenia, leukemia and so on are managed under Pediatric Hematology. Haematopoiesis is diverse in pediatric patients and children contrasted with grown-ups. By birth, basically all bone marrow depressions are effectively hematopoietic. In puerile, haematopoiesis moves to focal bones (vertebrae, sternum, ribs, pelvis). The red cells of the new-conceived are macrocytic and along these lines the blood film from a new-conceived newborn child shows macrocytic normochromic cells, polychromasia, and a few nucleated red platelets. Unfluctuating in solid newborn children could likewise be a light anisocytosis and poikilocytosis. Blood consistency, oxygen conveyance, Iron and moving substance, red cell antigens and heaps of different provisions are diverse in children and adolescents contrasted with the grown-ups. Subsequently an intensive exploration empowering a legitimate determination and therapy of the relative multitude of hematological issues in youngsters and pediatric patients is profoundly essential.

Track 17: Haematology and Pharma Industry
The overall market of the hematological meds in top point since it is generally expected to be upgraded over the years and years. According to the overall market master the hematology sedate and expressive market is depended upon to create at the pace of 7.5% from 2015-2021. Probably the most elevated drug store businesses delivering Biological Drugs and Generic Drugs join. Takeda oncology, Bristol-Mayers Squibb, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, AstraZeneca, Merck and Co., Amgen, Janssen biotech, Pfizer, Astellas, Bayer, Otsuka, Sanofi, Eisai, AbbVie, Merck KGaA, Pharmacyclics and Incyte.

Track 18: Hematology: Diagnostics and Screening
The channel of medication that bothered with the learning of the beginning, finding, treatment and expectation of infections identified with blood. It includes treating illnesses that mark the creation of blood and its parts, for instance platelets, blood proteins, bone marrow, hemoglobin, platelets, spleen, veins and the technique for coagulation. Such illnesses may accept hemophilia, blood clusters, added draining problems and blood diseases like leukemia, lymphoma and numerous myeloma. The test community trudge that goes into the investigation of blood is intermittently performed by a clinical technologist or clinical research center researcher. Treating of blood issue might vary for each specific problem, this can incorporate utilization of coagulation factor support, resistant regulating treatments, chemotherapy, bone marrow transplantation palliative consideration should be taken for the patients with complex issue. Normally, through actual examinations, clinical reports are utilized to recognize the infirmities by doctors to start the best treatment.

Track 19: Biomarkers in Hematology and Oncology
Biomarkers are the organic particles found in blood, other body liquids, or tissues, which clarifies an image of a typical or abnormal movement, or of a condition or disease. These are utilized to perceive how well the body answers to a treatment for an ailment or confusion. These are additionally characterized as atomic marker and mark particle. A malignant growth biomarker is a quality or substance that recognizes the event of disease in the body that are especially connected with hereditary transformations, which decide if people are helpless to specific sort of disease.

Biomarkers are utilized in three head modes in medication and disease research:
1. To help recognize grievances in the ID of beginning stage Malignances
2. To anticipate how hostile an affliction is (Prognostic)
3. To conceive how strong a patient will counter to treatment

Track 20: Immunohematology
Immunohematology alluded to be blood banking. This is the lab medication managing planning blood parts, blood for suitable choice and bonding and furthermore parts that are viable for bonding which is valuable if there should arise an occurrence of extreme blood misfortune or low blood levels. In the event that the choice and similarity bomb this may coordinates to hurt the kidneys, lungs and may be life threating. Bonding is regularly suggested simply in the event of sickness, consumes, malignancy, injury. People get inoculated when there are past bondings of blood or in the event of pregnancy. Red platelets contain antigens and protein markers on their surfaces, if beneficiary or givers red platelets doesn't contain this antigen the antigen lacking individual will prompt structure antibodies which obliterates the red blood cells.so what blood donation centers screens, composing and cross coordinating are completed for blood and its parts before the bondings. In the event that resistant arrangement of beneficiary assaults the contributor red platelets this state knows to be haemolytic response. Some of the time hives and tingling can likewise be noticed.

Market Analysis

Note: The global hematology analyzer market size was valued at $1,962.40 million in 2020 and is projected to reach $3,941.10 million by 2030 registering a CAGR of 7.30% from 2021 to 2030. Hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample.

Hematology Market is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2021 to 2027. Blood disorders are substantial health and economic burden in worldwide populations. The growing prevalence of common blood disorders such as anemia particularly among women and hemophilia has been driving clinical advances in the hematology market. The prevalence of certain blood cancer in developed countries is also bolstered awareness for hematology testing. The Global Hematology Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

The increasing incidence of blood-related disorders is expected to propel the growth of the global hematology market. The rising incidence of blood cancer is a major factor contributing to the growth of the market. For instance, according to GLOBOCAN 2018, more than 1.85 million new blood cancer cases are expected to be diagnosed in 2040 across the globe. Furthermore, according to the American Cancer Society, Non-Hodgkin lymphoma is one of the more common types of cancer in the U.S., accounting for 4% of all cancer cases. An estimated 74,680 patients were diagnosed with Non-Hodgkin lymphoma in the U.S. in 2018. In addition, increasing incidence of hemophilia and sickle-cell anemia is expected to drive the growth of the global hematology market. For instance, according to the World Federation of Hemophilia’s (WFH) 2018 statistics, around 440,000 people had hemophilia, out of which around 173,000 people were diagnosed with hemophilia A or B in 2017 globally. Furthermore, as per the World Health Organization, in 2018, the prevalence of anemia in children was around 45% and 12% in men, and it is increasing rapidly all over the world. Similarly, According to the National Institute of Health (NIH), anemia affects 30% of women of reproductive age and 40% of pregnant women, globally. Stringent regulatory and reimbursement policies on product launches, as well as product recalls due to safety violations are projected to hamper the growth of the market over the forecast period. For instance, in April 2017, Sysmex, a Japanese medical devices company recalled 3,682 XN Series Automated Hematology Analyzers, owing to increases in incidences of fire caused due to improper alignment of an internal protective sheet that protects electronic components from salty reagents used in hematological sample analysis.

Furthermore, an increasing number of product launches is expected to propel the market growth over the forecast period. New product launches by key players operating in the global market are expected to propel the growth of the global hematology market. For instance, in May 2018, Beckman Coulter, a Danaher Corporation company that develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing, launched the DxH 900 hematology analyzer which performs complete blood count and white blood cell differential tests with minimal repeats for application in mid-to high-volume clinical laboratories. In February 2018, Horiba, a Japanese manufacturer of precision instruments for measurement and analysis, launched the Yumizen G range of semi-automatic to fully automatic hemostasis solutions for clinical testing. Moreover, the increasing adoption of certifications for quality enhancement by key players operating in the global hematology market is expected to propel the market growth over the forecast period. In November 2017, Sysmex received CLIA Waiver certification under the U.S. regulatory approval system for the XW-100 automated hematology analyzer. It is the latest product in the hematology field targeting the U.S. market.

Past Conference Report

Conferenceseries llc LTD organized the 21^st World Hematology Congress during February 20-21, 2023 as a Webinar. The conference organized with a focus on “Breezes of transformation and revolution in Hematology” was a great success where eminent keynote speakers from various reputed institutions with their magnificent presence addressed the gathering.

The conference was commenced with an opening ceremony followed by Keynote sessions and followed by series of lectures delivered by both Honourable Guests and members of the Keynote forum.

Conferenceseries llc LTD offers well appreciation to Organizing Committee Members, dexterous of field, various outside experts, company representatives and is obliged to other eminent personalities who interlaced with Conferenceseries llc LTD and supported the conference in every aspect, without which the conference would not have been possible. Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the success of Hematology 2023, Conferenceseries llc LTD would like to announce the upcoming on “22^nd World Hematology Congress” to be held during February 19-20, 2024 London, UK. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Hematology Research.

For more details: https://hematology.insightconferences.com/